TREA

88780321 - ESPEROVAX

Follow

Information

  • Trademark
  • 88780321
  • Serial Number
    88780321
  • Filing Date
    January 31, 2020
    5 years ago
  • Transaction Date
    February 26, 2024
    11 months ago
  • Status Date
    February 26, 2024
    11 months ago
  • Published for Opposition Date
    December 01, 2020
    4 years ago
  • Location Date
    August 03, 2023
    a year ago
  • Status Code
    606
  • Current Location
    INTENT TO USE SECTION
    Employee Name
    LINDEMYER, ANKHI MUKHE
  • Attorney Docket Number
    61930-US-NF
    Attorney Name
    J. Matthew Buchanan
    Law Office Assigned Location Code
    N50
  • Owners
Information
Mark Drawing Code
4000
Mark Identification
ESPEROVAX
Case File Statements
  • GS0051: Vaccines; Oral vaccines; Modified cells for medical or clinical use; Pharmaceuticals in the nature of yeast-based pharmaceuticals; Oral vaccine preparations; Pharmaceutical products for the treatment of infectious diseases; Recombinant yeast-based pharmaceutical products; Yeast-based oral vaccines; Pharmaceutical preparations, namely, a drug delivery system comprising yeast-based oral vaccines; Pharmaceutical products, namely, yeast-based oral vaccines; Biological and pharmaceutical preparations, namely, recombinant yeast for medical use
  • GS0421: Medical research in the field of vaccines and medicines; Research and development of vaccines and medicines; Research and development in the pharmaceutical and biotechnology fields; Scientific research in the field of vaccines and medicines; Pharmaceutical research and development; Research and development in the field of immunology; Research and development in the field of microorganisms, namely, research and development related to yeast; Research and development in the field of therapeutics; Development of pharmaceutical preparations and medicines; Scientific study and research in the field of medicine; Scientific study and research in the field of healthcare products; Medical and scientific research; Discovery, development and design of pharmaceutical and therapeutic preparations; Pharmaceutical, biologic, and vaccine research and development
Case File Event Statements
  • 2/26/2024 - 11 months ago
    42 - ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED Type: MAB6
  • 2/26/2024 - 11 months ago
    41 - ABANDONMENT - NO USE STATEMENT FILED Type: ABN6
  • 8/4/2023 - a year ago
    40 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA
  • 8/3/2023 - a year ago
    39 - SOU EXTENSION 5 GRANTED Type: EX5G
  • 7/25/2023 - a year ago
    38 - SOU EXTENSION 5 FILED Type: EXT5
  • 8/3/2023 - a year ago
    37 - CASE ASSIGNED TO INTENT TO USE PARALEGAL Type: AITU
  • 7/25/2023 - a year ago
    36 - SOU TEAS EXTENSION RECEIVED Type: EEXT
  • 1/21/2023 - 2 years ago
    35 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA
  • 1/19/2023 - 2 years ago
    34 - SOU EXTENSION 4 GRANTED Type: EX4G
  • 1/19/2023 - 2 years ago
    33 - SOU EXTENSION 4 FILED Type: EXT4
  • 1/19/2023 - 2 years ago
    32 - SOU TEAS EXTENSION RECEIVED Type: EEXT
  • 7/14/2022 - 2 years ago
    31 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA
  • 7/12/2022 - 2 years ago
    30 - SOU EXTENSION 3 GRANTED Type: EX3G
  • 7/12/2022 - 2 years ago
    29 - SOU EXTENSION 3 FILED Type: EXT3
  • 7/12/2022 - 2 years ago
    28 - SOU TEAS EXTENSION RECEIVED Type: EEXT
  • 3/7/2022 - 2 years ago
    27 - ASSIGNED TO EXAMINER Type: DOCK
  • 1/27/2022 - 3 years ago
    26 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA
  • 1/25/2022 - 3 years ago
    25 - SOU EXTENSION 2 GRANTED Type: EX2G
  • 1/25/2022 - 3 years ago
    24 - SOU EXTENSION 2 FILED Type: EXT2
  • 1/25/2022 - 3 years ago
    23 - SOU TEAS EXTENSION RECEIVED Type: EEXT
  • 7/15/2021 - 3 years ago
    22 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA
  • 7/13/2021 - 3 years ago
    21 - SOU EXTENSION 1 GRANTED Type: EX1G
  • 7/13/2021 - 3 years ago
    20 - SOU EXTENSION 1 FILED Type: EXT1
  • 7/13/2021 - 3 years ago
    19 - SOU TEAS EXTENSION RECEIVED Type: EEXT
  • 7/8/2021 - 3 years ago
    18 - TEAS CHANGE OF CORRESPONDENCE RECEIVED Type: TCCA
  • 7/8/2021 - 3 years ago
    17 - TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS Type: EWAF
  • 7/8/2021 - 3 years ago
    16 - ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Type: ARAA
  • 7/8/2021 - 3 years ago
    15 - TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Type: REAP
  • 1/26/2021 - 4 years ago
    14 - NOA E-MAILED - SOU REQUIRED FROM APPLICANT Type: NOAM
  • 12/1/2020 - 4 years ago
    13 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 12/1/2020 - 4 years ago
    12 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 11/11/2020 - 4 years ago
    11 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 10/22/2020 - 4 years ago
    10 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 10/21/2020 - 4 years ago
    9 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 10/21/2020 - 4 years ago
    8 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 10/21/2020 - 4 years ago
    7 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 4/22/2020 - 4 years ago
    6 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN
  • 4/22/2020 - 4 years ago
    5 - NON-FINAL ACTION E-MAILED Type: GNRT
  • 4/22/2020 - 4 years ago
    4 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 4/21/2020 - 4 years ago
    3 - ASSIGNED TO EXAMINER Type: DOCK
  • 2/5/2020 - 5 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 2/4/2020 - 5 years ago
    1 - NEW APPLICATION ENTERED Type: NWAP